A Case of Metastatic Clear Cell Renal Cell Carcinoma Showing Long-Term Complete Response after the Discontinuation of Tyrosine Kinase Inhibitor

Randomized phase III trials demonstrated superiority of targeted therapy with tyrosine kinase inhibitors over cytokine-based therapy as first-line therapy for metastatic renal cell carcinoma. However, the rate of complete response (CR) with targeted therapy is smaller than that with cytokine-based t...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 64(2018), 12 vom: 08. Dez., Seite 483-487
1. Verfasser: Hayata, Naoki (VerfasserIn)
Weitere Verfasser: Yoshida, Toru, Hama, Yusuke, Sunada, Takuro, Masuda, Norihiko, Yoshikawa, Takeshi, Satogami, Naoe, Segawa, Takehiko
Format: Online-Aufsatz
Sprache:Japanese
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Journal Article Antineoplastic Agents Pyrroles Protein-Tyrosine Kinases EC 2.7.10.1